Test drug for frequent cold sores in the mouth
Part of Infections, Skin clinical trials.
This trial tests whether 2LHERP® can reduce or manage frequent herpes infections around the mouth. It compares the study drug to a placebo (inactive treatment) in people who get many episodes each year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 16 to 80
- You’ve had 6 or more mouth herpes episodes in the last 12 months
- If you can become pregnant: you’re not pregnant and use effective birth control during the study
- You have a steady sexual partner and can keep that during the study
- You can understand the study and agree to follow it, including follow-up visits
- You can take part for about 12 months and likely can attend visits through the end
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication called UB-621, given as repeated doses, to see if it is safe and effective in reducing recurrent genital herpes outbreaks in adults. If you have frequent outbreaks (6 to 12 per year), this trial might help you find a new treatment option.
This trial tests whether a medicine called acyclovir can prevent herpes simplex outbreaks in people who also have an autoimmune rheumatic disease. It may help reduce the number of painful cold sores or genital herpes episodes you experience.
This study tests whether a daily benzoyl peroxide cream can stop cold sores (caused by HSV-1) from coming back. You may join from home through video visits, and if you have an outbreak during the trial, you'll get the standard treatment.
This study tests whether a pharmacist-led program can improve the quality of prescribing for people with oral mucosal disorders (conditions affecting the lining of the mouth). If you have such a condition and are prescribed medication, you may be able to join.
This trial offers a new antiviral medicine called pritelivir to people with weakened immune systems who have herpes sores that do not get better with standard treatments. Taking pritelivir may help clear these resistant sores when other options have failed.
This trial tests a mouthwash for oral lichen planus, a chronic condition causing painful sores in the mouth. The mouthwash contains hyaluronic acid and a peptide that may help reduce pain and irritation. If it works, it could offer a new treatment option.
Hear when a new Herpes Simplex trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.